Editorial: Identification of Multiple Targets in the Fight Against Alzheimer's Disease

by Patrizia Giannoni, Silvia Fossati, Elena Marcello, Sylvie Claeysen
Published 2020-06-01

Peripheral Routes to Neurodegeneration: Passing Through the Blood–Brain Barrier

by Patrizia Giannoni, Sylvie Claeysen, Francesco Noe, Nicola Marchi
Published 2020-02-01

Modifying ligand-induced and constitutive signaling of the human 5-HT4 receptor.

by Wei Chun Chang, Jennifer K Ng, Trieu Nguyen, Lucie Pellissier, Sylvie Claeysen, Edward C Hsiao, Bruce R Conklin
Published 2007-12-01

Phosphorylation of β-arrestin2 at Thr383 by MEK underlies β-arrestin-dependent activation of Erk1/2 by GPCRs

by Elisabeth Cassier, Nathalie Gallay, Thomas Bourquard, Sylvie Claeysen, Joël Bockaert, Pascale Crépieux, Anne Poupon, Eric Reiter, Philippe Marin, Franck Vandermoere
Published 2017-02-01

A Novel in vivo Anti-amnesic Agent, Specially Designed to Express Both Acetylcholinesterase (AChE) Inhibitory, Serotonergic Subtype 4 Receptor (5-HT4R) Agonist and Serotonergic Sub...

by Bérénice Hatat, Bérénice Hatat, Samir Yahiaoui, Cédric Lecoutey, Audrey Davis, Thomas Freret, Michel Boulouard, Sylvie Claeysen, Christophe Rochais, Patrick Dallemagne
Published 2019-06-01

Cerebrovascular pathology during the progression of experimental Alzheimer's disease

by Patrizia Giannoni, Margarita Arango-Lievano, Ines Das Neves, Marie-Claude Rousset, Kévin Baranger, Santiago Rivera, Freddy Jeanneteau, Sylvie Claeysen, Nicola Marchi
Published 2016-04-01

Inhibiting Acetylcholinesterase to Activate Pleiotropic Prodrugs with Therapeutic Interest in Alzheimer’s Disease

by François-Xavier Toublet, Cédric Lecoutey, Julien Lalut, Bérénice Hatat, Audrey Davis, Marc Since, Sophie Corvaisier, Thomas Freret, Jana Sopkova de Oliveira Santos, Sylvie Claeysen, Michel Boulouard, Patrick Dallemagne, Christophe Rochais
Published 2019-07-01